These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26933916)

  • 1. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
    Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients.
    Trebo A; Ditsch N; Kuhn C; Heidegger HH; Zeder-Goess C; Kolben T; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Hester A
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varied expression and localization of multiple galectins in different cancer cell lines.
    Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
    Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
    Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
    Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of galectins in cancer: a critical review.
    van den Brûle F; Califice S; Castronovo V
    Glycoconj J; 2002; 19(7-9):537-42. PubMed ID: 14758077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.
    Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7.
    Lohr M; Kaltner H; Lensch M; André S; Sinowatz F; Gabius HJ
    Histochem Cell Biol; 2008 Sep; 130(3):567-81. PubMed ID: 18597104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic binding studies of galectin-1, -3 and -7.
    Brewer CF
    Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degraded Arabinogalactans and Their Binding Properties to Cancer-Associated Human Galectins.
    Pfeifer L; Baumann A; Petersen LM; Höger B; Beitz E; Classen B
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
    Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
    Front Immunol; 2020; 11():1820. PubMed ID: 33013832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Galectins in Multiple Myeloma.
    Storti P; Marchica V; Giuliani N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.
    Schulkens IA; Heusschen R; van den Boogaart V; van Suylen RJ; Dingemans AM; Griffioen AW; Thijssen VL
    PLoS One; 2014; 9(9):e107988. PubMed ID: 25259711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.
    Grosset AA; Labrie M; Gagné D; Vladoiu MC; Gaboury L; Doucet N; St-Pierre Y
    BMC Cancer; 2014 Nov; 14():801. PubMed ID: 25367122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis in humans is associated with down-regulation of galectins in dendritic cells.
    de la Fuente H; Perez-Gala S; Bonay P; Cruz-Adalia A; Cibrian D; Sanchez-Cuellar S; Dauden E; Fresno M; García-Diez A; Sanchez-Madrid F
    J Pathol; 2012 Oct; 228(2):193-203. PubMed ID: 22271227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3.
    Pirone L; Nieto-Fabregat F; Di Gaetano S; Capasso D; Russo R; Traboni S; Molinaro A; Iadonisi A; Saviano M; Marchetti R; Silipo A; Pedone E
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
    Ajani JA; Estrella JS; Chen Q; Correa AM; Ma L; Scott AW; Jin J; Liu B; Xie M; Sudo K; Shiozaki H; Badgwell B; Weston B; Lee JH; Bhutani MS; Onodera H; Suzuki K; Suzuki A; Ding S; Hofstetter WL; Johnson RL; Bresalier RS; Song S
    Br J Cancer; 2018 Jan; 118(1):52-61. PubMed ID: 29136404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 Inhibits Galectin-8/Parkin-Mediated Ubiquitination of Group A Streptococcus.
    Cheng YL; Wu YW; Kuo CF; Lu SL; Liu FT; Anderson R; Lin CF; Liu YL; Wang WY; Chen YD; Zheng PX; Wu JJ; Lin YS
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
    Aggarwal S; Sharma SC; Das SN
    Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.